IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Celsus Therapeutics PLC

CUSIP: 15119A202 | 20 institutional holders

Quarters

Q2 2015Q1 2015Q4 2014Q3 2014Q2 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2015

Cormorant Asset Management, LP286,508
0.0% of portfolio›$166
Citadel Advisors LLC15,249
0.0% of portfolio›$9
UBS Group AG3,350
0.0% of portfolio›$2
American International Group, Inc.600
0.0% of portfolio›$348
Morgan Stanley8
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Cormorant Asset Management, LP
286,508$1660.0%CoreMediumBoston, MA2015-08-14
Citadel Advisors LLC
15,249$90.0%CoreVery HighMiami, FL2016-02-05
UBS Group AG
3,350$20.0%CoreMediumZurich, Switzerland2015-08-14
American International Group, Inc.
600$3480.0%Agg GrowthVery LowNew York, NY2015-08-26
Morgan Stanley
8$00.0%CoreLowNew York, NY2015-08-12